Advertisement

Topics

EMA To Discuss Reactivating Landmark Clinical Trials Transparency Policy

07:17 EDT 12 Oct 2018 | Elsevier Business Intelligence

The European Medicines Agency will be looking at reviving its policy on proactive publishing of clinical study reports, which...

Original Article: EMA To Discuss Reactivating Landmark Clinical Trials Transparency Policy

NEXT ARTICLE

More From BioPortfolio on "EMA To Discuss Reactivating Landmark Clinical Trials Transparency Policy"

Advertisement
Quick Search
Advertisement
Advertisement